HUTCHMED stock holds at USD 13.67 as market cap reaches USD 2.376 billion

HUTCHMED (ISIN US44842L1035) stood at USD 13.67 on September 21, 2026, while the company carried a market capitalization of USD 2.376 billion. The stock was down 1.09 percent in the quoted market snapshot, giving investors a precise reference point for the latest completed trading session.

Specialty drugs define the profile

The company is classified as a specialty and generic drug manufacturer in the available market data. That classification places the share in a segment where product approvals, commercial launches and sales execution matter more than broad biotechnology labels.

The latest market snapshot supplies a current valuation measure, but the available quote does not provide a dated revenue, earnings or margin figure that can be responsibly presented as a recent operating result. The USD 2.376 billion market capitalization therefore remains the clearest quantified company-specific market measure for September 21, 2026.

Price gives the current reference

HUTCHMED stock was quoted at USD 13.67 on September 21, 2026, with a daily change of minus 1.09 percent. The combination of the price and market value provides a dated basis for comparing later company updates with the market position established at the latest completed session.

Market value remains measurable

The company had a market capitalization of USD 2.376 billion as of September 21, 2026. For investors assessing the next operating update, that figure is the relevant starting valuation, while the stock's specialty-drug classification identifies the business area driving the market narrative.

More news and analyses on HUTCHMED stock